Potential Health Impact and Cost-Effectiveness of Bivalent Human Papillomavirus (HPV) Vaccination in Afghanistan
This article, published in Vaccine, reports the results of a modelling study that estimated the potential health impact and cost-effectiveness of human papillomavirus (HPV) vaccination in Afghanistan to help inform national decision-making. The results indicate that in Afghanistan, HPV vaccine introduction is likely cost-effective compared to no vaccination. In all scenario explored, including a catch-up campaign with the introduction of routine HPV immunization was more cost-effective than routine immunization alone. In addition to reducing burden on the health system, preventing downstream disease would reduce the financial and economic shocks imposed on women and their families.
Author: Anwari P, Debellut F, Vodicka E, et al.
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Anwari P, Debellut F, Vodicka E, et al. Potential Health Impact and Cost-Effectiveness of Bivalent Human Papillomavirus (HPV) Vaccination in Afghanistan. Vaccine. 2020;38(6):1352-1362.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)
Regions: Middle East